Company: RPTX
Filing Date: 2025-06-02
Form Type: 8-K/A
Source: 0001193125-25-133312
Chunk: 0

Company: Repare Therapeutics Inc.
Filing Date: 2025-06-02
Form: 8-K/A
Chunk 0
---
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K /A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 31, 2025 Repare Therapeutics Inc. (Exact Name of Registrant as Specified in Its Charter)

| Québec                                        |     | 001-39335              |     | Not applicable                     |
| (State or Other Jurisdictionof Incorporation) |     | -CommissionFile Number |     | -I.R.S. EmployerIdentification No. |

| 7171 Frederick-Banting, Building 2, Suite 270St-Laurent, Québec, Canada |     | H4S 1Z9   |
| (Address of Principal Executive Offices)                                |     | -Zip Code |

Registrant’s Telephone Number, Including Area Code: ( 857) 412-7018 Not Applicable (Former Name or Former Address, if Changed Since Last Report.) Check the appropriate box below if the Form 8-Kfiling is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |

| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |

| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |

| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |

Securities registered pursuant to Section 12(b) of the Act:

| Title of each class         |     | Trading 
 Symbol  |     | Name of each exchangeon which registered |
| Common shares, no par value |     | RPTX    |     | The Nasdaq Stock Market LLC              |

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2of the Securities Exchange Act of 1934 (§240.12b-2of this